About
Jeff Liu holds a PhD in oncology from Oxford and previously founded Vivid Dx, which developed a diagnostic approach for sepsis that reduced testing time from five days to thirty minutes. He is now CEO of FinalDose, a YC-backed company.
Founder at FinalDoseYC X26
Intro paths
YC
Jeff went through Y Combinator (Spring 2026) — any YC alum in your network can reach them through the YC community.
GP
Their group partner at YC was Garry Tan, President & CEO of Y Combinator — the partner who ran FinalDose's batch and knows the company first-hand. YC profile ↗
→
In turn, Jeff can intro founders to FinalDose's investors below.
FinalDose's investors · 4
Co-founders at FinalDose
LH
Li-Yao HuangFounder
SL
Steven LinFounder